Start: $100 fund cash, $1000 equity; query_trades empty, so no holdings to reset, closed-trade lessons, fill/slippage estimates or stop/target-hit statistics. Goal: executable convex long-option exposure. Binding constraints: $50 premium per ticket, $100 total, max2, >=6 same-kind events, OI>=100/positivebid/spread<=40%, expiry>=event+7; orders only09:50/12:30 DAYlimits. This is a closed research run. Premises: 1 issuer LW Oct6 date remains published; 2 inclusive N11 median10.0174/P8020.1075%; 3 P40 .33/.48,OI312,31.25%spread passes numerical liquidity and5.65455x P80 test; 4 hurdle15.3203% demands prior-session exit, historical bracket diagnostics and conditional model do not support that implementation. Conclusion valid conditionally; soundness limited by stale indicative quotes and sparse option paths, not the period funding target. Best rejected implementation is LW261016P00040000,48USD fullrisk. Alternative P42.5 grossmedian priceceiling.505107, costscenario.485107, versus current1.02ask; stock/quote changes require complete recomputation. Nominal future.48 entry stop.24,target1.44 gives96USD targetprofit, not promised payoff. No honest present model supports a whole48USD ticket at halfKelly; model itself is not permanent veto. NewCALM N12 median2.5597/P804.9781 rejectsC95.08 despiteOI170/12.5%spread: hurdle30.4431/P80zero. Sixteen selected-expiry chains and seven price-regime checks completed; not exhaustive whole-market coverage. LEVI primary futuredate missing; FDA/court matched panels and directcrypto-option coverage remain gaps, not presumed nonexistent. No new primary change found in bounded LW/CALM newsroom checks. Sources: https://news.lambweston.com/news-releases/news-release-details/lamb-weston-announce-fiscal-year-2027-first-quarter-financial ; https://calmainefoods.gcs-web.com/news-releases/news-release-details/cal-maine-foods-schedules-first-quarter-fiscal-2027-earnings ; https://runway.adityaperswal.workers.dev/data/stock-bars ; /data/option-chain/LW?feed=indicative . Existing Monday441/442/452 reviews retained; new462 next02UTC,463/464 CALM accepted. Jobs285/286 healthy actualremoteEND2/2, next00:31/01:46, retained. No orders queued and no FUND proposal. Two-flat-trading-run breach cannot be inferred from this research run; act on fresh qualifying live candidates at authorized runs rather than repeat unsupported caution. Analyses3757–3764 and observations31057–31132 provide figures and counterarguments.
equity1000
fund_cash100
holdings0
orders0
screen_names16
LW_premium48
LW_P80_multiple5.65
LW_hurdle_pct15.32
LW_median_pct10.02
LW_P42_5_costed_ceiling0.49
CALM_P80_multiple0
own_trade_sample0
R92008 pre-open decision: no research-session order; explicit re-entry thresholds
Start $100fund cash/$1000 equity,0 own holdings/orders/trades; goal executable long-option asymmetry. Binding constraints $50singlepremium,$100total,max2,>=6matched events, OI>=100,bid>0,spread<=40%,expiry>=event+7,DAYlimits only09:50/12:30. Own5 existing monitors none due; other funds' stale due items untouched. Screen15 chains and61volume/gainer names; no whole-market exhaustive claim. Best rejected ticket LW261016P00040000 S46.67 ask.48bid.33 OI312 spread31.25%, N11median10.0174/P8020.1075,hurdle15.3203%,P80payoff2.71418=5.65455x: numerical payoff/liquidity pass, but Friday indicative quotes not live execution and required Oct5pre-event exit has8costed losing endpoints/0complete affordable paths, prior simulation mean-$16.76. This is an implementation gap, not denial of gross pass or a permanent model veto. No entry this closed research run regardless. BB N13 Oct2C8.5 .43 hurdle11.7647>9.1153median/P801.1985x; full12 NKE Oct9P32 .47 hurdle11.2081>6.8357/P803.5011x; SFIXP2.5 .28 hurdle21.831>16.578/P801.972x and89.29%spread. MLKN mincall.52/OI2 bid0,put.63/OI1 reject. What changes mind: fresh nearer affordable liquid leg, BB C8.5 grossmedian price<=.21831 at unchangedS (costscenario<=.19831), or independently supported pre-event strategy for tail-only LW/NKE; reprice all figures rather than rely on thresholds. NKE grossP80 price<=.41138 alone still requires pre-event exit. Stops for any qualified future fill .5paid, target3xpaid or defendedP80; no contingent order represented as queued. HalfKelly from BB policy simulation0, no honest probability supporting present LW whole48USD ticket; cap is ceiling not allocation. Two-flat-trading-run breach not inferable from research runs; review live qualifying opportunities at441/442/452 without indefinite deferral. MonABVX dateonly/spending11ET; TueMLKNBMO/Philly08:30/Richmond10ET/H6 13ET (calendar3703). IONSSep22obsolete, FDA full coverage unknown, GRALSep23panel notapproval. New452–454 monitors accepted, job286 BB/NKE120min60runs localEND2/2; preserve285 and438–443. No orders, no close lessons outstanding. Source URLs in3703,3714,3728 and underlying observations; https://runway.adityaperswal.workers.dev/data/stock-bars .
fund_cash100
single_premium_cap50
LW_premium48
LW_p80_multiple5.65
LW_hurdle_percent15.32
LW_median_percent10.02
BB_p80_multiple1.2
NKE_p80_multiple3.5
orders0
R92008 verified two-session calendar and monitor audit
Premises: (1) own ledger empty and five monitors armed, none due; (2) ABVX issuer lists Sep21 H1 financial results, date only https://ir.abivax.com/events/event-details/h1-2026-financial-results/ ; (3) MLKN issuer Aug25 confirms Sep22 BMO release/08:30ET call https://news.millerknoll.com/2026-08-25-MillerKnoll-Schedules-First-Quarter-Fiscal-Year-2027-Conference-Call-and-Webcast ; (4) NYFed https://www.newyorkfed.org/research/calendars/i-sep26.html Sep21 household spending11ET, Sep22 Philly nonmanufacturing08:30/Richmond10ET; (5) Board https://www.federalreserve.gov/newsevents/2026-september.htm adds Sep22 Jefferson10:20ET/H6 13ET, CP13ET/H15 16:15ET both days and H10Mon16:15. IONS Sep22PDUFA obsolete: issuerSep3 approved zilganersen https://ir.ionis.com/news-releases/news-release-details/zanvastrotm-zilganersen-approved-fda-first-and-only-disease . FDA calendar empty rendered table means coverage gap, not zero decisions; GRAL official panel Sep23 09–18ET, outside two sessions, briefing publication could precede it. Event page currently links two conflict waivers, not full briefings. Conclusion: monitor primary cash/results and news timing, never treat calendar certainty as directional edge. Research run cannot queue options; earliest own entry review Monday13:50UTC. Stronger cash or weaker demand both update figures, neither automatic trade. Existing other-fund due monitors remain their responsibility.
own_due0
own_armed5
own_trades0
next_entry_UTC2026-09-21 13:50
MLKN_call_ET2026-09-22 08:30
ABVX_date2026-09-21
calendar_sessions2
R92006 decision: cash in research session; LW gross pass is not yet an executable pre-event trade